Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
Journal of Medical Economics
|
April 16, 2019
Examining the heterogeneity of treatment patterns in attention deficit hyperactivity disorder among children and adolescents in the Texas Medicaid population: modeling suboptimal treatment response
Regina Grebla, Juliana Setyawan, Chanhyun Park, et al.
Journal of Medical Economics
|
October 1, 2010
Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study
Andrew P Yu, Jipan Xie, Arielle Bensimon, et al.
The Annals of Pharmacotherapy
|
March 19, 2011
Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder
Eric Q Wu, Andrew P Yu, Veronique Lauzon, et al.
Applied Health Economics and Health Policy
|
April 18, 2013
Authors' reply to Alatorre et al.: "cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison"
M Haim Erder, Jipan Xie, James E Signorovitch, et al.
Journal of Medical Economics
|
June 23, 2011
Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costs
Andrew P Yu, Rym Ben-Hamadi, Eric Q Wu, et al.
Applied Health Economics and Health Policy
|
November 2, 2012
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison
M Haim Erder, Jipan Xie, James E Signorovitch, et al.
Journal of the American Medical Directors Association
|
October 30, 2010
Memantine discontinuation and the health status of nursing home residents with Alzheimer's disease
Howard Fillit, Robert K Hofbauer, Juliana Setyawan, et al.
Mechanisms of Ageing and Development
|
April 21, 2010
Aberrant heterodimerization of keratin 16 with keratin 6A in HaCaT keratinocytes results in diminished cellular migration
A Trost, P Desch, V Wally, et al.
CNS Drugs
|
August 27, 2013
Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology
Vanja Sikirica, Robert L Findling, James Signorovitch, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 25, 2012
Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research
James E Signorovitch, Vanja Sikirica, M Haim Erder, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
Journal of Medical Economics
|
April 16, 2019
Examining the heterogeneity of treatment patterns in attention deficit hyperactivity disorder among children and adolescents in the Texas Medicaid population: modeling suboptimal treatment response
Regina Grebla, Juliana Setyawan, Chanhyun Park, et al.
Journal of Medical Economics
|
October 1, 2010
Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study
Andrew P Yu, Jipan Xie, Arielle Bensimon, et al.
The Annals of Pharmacotherapy
|
March 19, 2011
Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder
Eric Q Wu, Andrew P Yu, Veronique Lauzon, et al.
Applied Health Economics and Health Policy
|
April 18, 2013
Authors' reply to Alatorre et al.: "cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison"
M Haim Erder, Jipan Xie, James E Signorovitch, et al.
Journal of Medical Economics
|
June 23, 2011
Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costs
Andrew P Yu, Rym Ben-Hamadi, Eric Q Wu, et al.
Applied Health Economics and Health Policy
|
November 2, 2012
Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison
M Haim Erder, Jipan Xie, James E Signorovitch, et al.
Journal of the American Medical Directors Association
|
October 30, 2010
Memantine discontinuation and the health status of nursing home residents with Alzheimer's disease
Howard Fillit, Robert K Hofbauer, Juliana Setyawan, et al.
Mechanisms of Ageing and Development
|
April 21, 2010
Aberrant heterodimerization of keratin 16 with keratin 6A in HaCaT keratinocytes results in diminished cellular migration
A Trost, P Desch, V Wally, et al.
CNS Drugs
|
August 27, 2013
Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology
Vanja Sikirica, Robert L Findling, James Signorovitch, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 25, 2012
Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research
James E Signorovitch, Vanja Sikirica, M Haim Erder, et al.
Page
of 12